InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001156039-24-000031 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-05 2024-03-01 ELV Kendrick Charles Morgan JR EVP, Pres, Commercial F - Tax $499.11 -1,484 13.8K -10% -$740.7K
DM 2024-03-05 2024-03-01 ELV Kendrick Charles Morgan JR EVP, Pres, Commercial A - Grant $0.00 +4,508 15.9K +40% $0
D 2024-03-05 2024-03-01 ELV Kendrick Charles Morgan JR EVP, Pres, Commercial A - Grant $0.00 +8,312 8,312 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-01 F D 1,484 $499.11 13,764 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
2 Common Common Stock 2024-03-01 A A 2,354 $0.00 18,272 D — — (F3) Represents performance based restricted share units. Restrictions lapse on 3/1/2024.
3 Common Common Stock 2024-03-01 A A 2,154 $0.00 15,918 D — — (F2) Represents restricted share units. Restrictions lapse as follows:718 shares on 3/1/2025, 3/1/2026, and 3/1/2027.
4 Derivative Employee Stock Option (Right to Buy) 2024-03-01 A A 8,312 $0.00 8,312 D $499.11 · — to 2034-03-01 8,312 Common Stock (F4) The option represents a right to purchase a total of 8,312 shares, and is exercisable in one installment of 2,770 shares, and two installments of 2,771 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.